FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Accelrys lays off 50 as it restates earnings


Free newsletter via e-mail
Tools

Accelrys, which makes software for drug discovery work, says it will lay off 50 workers as part of an effort to streamline operations. Accelrys announced last December that it would have to restate earnings over the past five years to properly account for the earnings from several of its contracts. The company also said it would close part of a facility it has in Cambridge, England. The cuts are designed to save Accelrys $6 million a year.

- here's the report from the San Diego Union-Tribune


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter: